ST. LOUIS, Jan. 12 Sigma-Aldrich® (Nasdaq: SIAL) announced today it has entered a distribution agreement with Eka Chemicals to offer Eka's Kromasil® analytical HPLC columns for the separation and purification of small molecules, peptides and proteins in the pharmaceutical and biotechnology industries. This agreement includes distribution in the U.S., Canada and Puerto Rico, and expands Sigma-Aldrich's portfolio of chromatography solutions offered through its Supelco® brand. In addition to the classic Kromasil phases, the new pH stable Kromasil Eternity(TM) C18 and Kromasil chiral phases are now available from Sigma-Aldrich at http://www.sigma-aldrich.com/kromasil.
Advertisement
"Kromasil analytical columns are useful tools to serve as a high performance spherical silica media for analytical to process-scale HPLC, SFC, and SMB applications," said Wayne K. Way, Ph.D., Sigma-Aldrich HPLC Marketing Manager. "Sigma-Aldrich is committed to being the complete chromatography solution provider, and this agreement enables us to provide more robust solutions for the research community."
Advertisement
Sigma-Aldrich's agreement with Eka complements Sigma-Aldrich's comprehensive collection of chromatography products that support applications in environmental testing, food and beverage analysis, air monitoring, gas chromatography, chiral chromatography and clinical industry applications. For more information on Sigma-Aldrich chromatography solutions, visit http://www.sigma-aldrich.com/chromatography.
The foregoing release contains forward-looking statements that can be identified by terminology such as "solutions," "useful tools," "provide more robust solutions," "comprehensive," or similar expressions, or by express or implied discussions regarding Kromasil HPLC columns, or regarding potential future revenues from products derived therefrom. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that products derived from Kromasil HPLC columns will continue to meet the demands of the marketplace. Nor can there be any guarantee that any of these products will achieve any particular levels of revenue in the future. In particular, management's expectations regarding these products could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Company's assets and liabilities as recorded in its consolidated balance sheet, and other risks and factors referred to in Sigma-Aldrich's current Form 10-K on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Sigma-Aldrich is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. Sigma-Aldrich has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 38 countries and has 7,800 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning website at http://www.sigma-aldrich.com.
Sigma-Aldrich and Supelco are registered trademarks of Sigma-Aldrich Biotechnology LP and Sigma-Aldrich Co. Kromasil is a registered trademark of EKA Chemicals AB.
SOURCE Sigma-Aldrich
